United States · Pharmaceuticals startup
United States · Cardeas Pharma Corp.
Cardeas Pharma develops a novel antibiotic formulation of two drugs with synergistic activity.
Funding reportedLast round: Series B
Follow Cardeas Pharma Corp. and see its new rounds in your feed.Start following
What company datasets say Cardeas Pharma Corp. raised
Funding, as reported
Reported in all$80Min dollars
Rounds3
Last roundSeries B
Last round size$38M
Last round dateApr 2015
Investors listed6
Founders and team
From the SEC filings it signed: 2 on the team.
- A. Bruce MontgomeryExecutive Officer, Director, Promoteri
- Melissa YeagerExecutive Officer, Promoteri
On the board, as filediAaron Bruce DavidsonAnthony Bruce ScullionKevin Bruce KinsellaPeter Bruce MoldtRobert Bruce deGavre
The company, in detail
What they build
Known for
health carehospital & health caremedicalhealthbiotechnologyhealthcarepharmaceuticalspharmaceutical manufacturingwellness & fitnesslife sciences
- Sector
- Pharmaceuticals
- Region
- Washington
- Revenue
- $7.5M a year, as listed
- Full record
- Every detail in the company directory
Pharmaceuticals in United States
Startups like it
ElevateBioWaltham · founded 2017Raised
Epirium BioSan Diego · founded 2008Raised
SpectronRxIndianapolis · founded 2004Raised
SollisGRANDVIEW · founded 2017Raised
Castle Creek PharmaceuticalsBernards · founded 2015Raised
Bryn PharmaRaleigh · founded 2016Raised
AeroSafe GlobalRochester · founded 1995Raised
AZTherapiesBoston · founded 2011Raised
Is this your company?
Add your raise, your deck and your story, and put Cardeas Pharma Corp. in front of investors. Or tell us what we have wrong.